Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Timothée Klopfenstein and Souheil Zayet.
Timothée Klopfenstein
Connection Strength
11.901
Souheil Zayet
  1. Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comté Hospital, France. Microorganisms. 2021 Aug 12; 9(8).
    View in: PubMed
    Score: 0.961
  2. Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'. Ann Rheum Dis. 2021 Jun 23.
    View in: PubMed
    Score: 0.952
  3. Recurrence of COVID-19 after recovery ? A case series in health care workers, France. Microbes Infect. 2021 May-Jun; 23(4-5):104803.
    View in: PubMed
    Score: 0.932
  4. Is There Still a Place for Tocilizumab in Coronavirus Disease 2019? Open Forum Infect Dis. 2021 Feb; 8(2):ofab013.
    View in: PubMed
    Score: 0.924
  5. Comparison of COVID-19 and influenza in adult patients: Neurological symptoms input. J Med Virol. 2021 04; 93(4):1893-1895.
    View in: PubMed
    Score: 0.919
  6. Natural history of COVID-19: back to basics. New Microbes New Infect. 2020 Nov; 38:100815.
    View in: PubMed
    Score: 0.913
  7. New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France. Int J Infect Dis. 2020 Nov; 100:117-122.
    View in: PubMed
    Score: 0.896
  8. Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster. Microbes Infect. 2020 10; 22(9):481-488.
    View in: PubMed
    Score: 0.887
  9. Diarrhea: An underestimated symptom in Coronavirus disease 2019. Clin Res Hepatol Gastroenterol. 2020 06; 44(3):282-283.
    View in: PubMed
    Score: 0.879
  10. Features of anosmia in COVID-19. Med Mal Infect. 2020 Aug; 50(5):436-439.
    View in: PubMed
    Score: 0.877
  11. It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2022 02 11; 74(3):560-562.
    View in: PubMed
    Score: 0.249
  12. Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia. Infect Dis Ther. 2021 Sep; 10(3):1195-1213.
    View in: PubMed
    Score: 0.239
  13. Distinguishing coronavirus disease 2019 from influenza in children remains challenging. New Microbes New Infect. 2021 May; 41:100888.
    View in: PubMed
    Score: 0.235
  14. Tocilizumab in COVID-19 pneumonia: Practical proposals based on a narrative review of randomised trials. Rev Med Virol. 2022 01; 32(1):e2239.
    View in: PubMed
    Score: 0.235
  15. A Comparative Systematic Review of COVID-19 and Influenza. Viruses. 2021 03 10; 13(3).
    View in: PubMed
    Score: 0.233
  16. Angioedema and COVID-19: A New Dermatological Manifestation? Infect Dis Rep. 2021 Jan 01; 13(1):23-25.
    View in: PubMed
    Score: 0.230
  17. Coronavirus disease 2019 with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema, France. New Microbes New Infect. 2020 Nov; 38:100785.
    View in: PubMed
    Score: 0.227
  18. Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients. Int J Infect Dis. 2020 Oct; 99:491-495.
    View in: PubMed
    Score: 0.224
  19. Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration. Clin Exp Rheumatol. 2020 Jul-Aug; 38(4):742-747.
    View in: PubMed
    Score: 0.222
  20. Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19). Microbes Infect. 2020 10; 22(9):500-503.
    View in: PubMed
    Score: 0.222
  21. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020. Emerg Infect Dis. 2020 Sep; 26(9).
    View in: PubMed
    Score: 0.221
  22. Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients. Med Mal Infect. 2020 Aug; 50(5):397-400.
    View in: PubMed
    Score: 0.220
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.